Turning Point Therapeutics, Inc.
DelistedCIK 1595893fmd_10P46GY71MV07EMR2WZEYQ1J33Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Jun 30, 2022, 19 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Total revenues | – | – | – | 25 | 31 |
| Research and development | 15 | 21 | 58 | 113 | 193 |
| Total operating expenses | 17 | 26 | 78 | 187 | 269 |
| Operating income | (17) | (26) | (78) | (162) | (238) |
| Income tax expense | – | 0 | 0 | 0 | 0 |
| Net income | (17) | (25) | (72) | (157) | (237) |